Novel therapeutic perspectives in pulmonary arterial hypertension

Humbert M., Sitbon O., Simonneau G.

Source: Eur Respir J 2003; 22: 193-194
Journal Issue: August
Disease area: Pulmonary vascular diseases

PDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Humbert M., Sitbon O., Simonneau G.. Novel therapeutic perspectives in pulmonary arterial hypertension. Eur Respir J 2003; 22: 193-194

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Novel techniques for advancing our understanding of pulmonary arterial hypertension
Source: Eur Respir J, 53 (5) 1900556; 10.1183/13993003.00556-2019
Year: 2019



Identification of treatment goals in paediatric pulmonary arterial hypertension
Source: Eur Respir J 2014; 44: 1616-1626
Year: 2014



The future of treatment for pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014

The future of treatment for pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

The future of treatment for pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012


The future of treatment for pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Novel biomarkers in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


New horizons in pulmonary arterial hypertension therapies
Source: Eur Respir Rev 2013; 22: 503-514
Year: 2013



Future perspectives in pulmonary arterial hypertension
Source: Eur Respir Rev 2016; 25: 381-389
Year: 2016



Challenging the concept of adding more drugs in pulmonary arterial hypertension
Source: Eur Respir J, 50 (3) 1701527; 10.1183/13993003.01527-2017
Year: 2017



Novel insights into the pathogenesis of pulmonary arterial hypertension
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020


Targeting HIF2a-ARNT hetero-dimerisation as a novel therapeutic strategy for pulmonary arterial hypertension
Source: Eur Respir J, 57 (3) 1902061; 10.1183/13993003.02061-2019
Year: 2021



New horizons in pulmonary arterial hypertension management
Source: Eur Respir Rev 2014; 23: 408-409
Year: 2014


The challenges in paediatric pulmonary arterial hypertension
Source: Eur Respir Rev 2014; 23: 498-504
Year: 2014



Current medical treatment of pulmonary arterial hypertension
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

Current medical treatment of pulmonary arterial hypertension
Source: School Course 2012 - Pulmonary hypertension and pulmonary vascular disease
Year: 2012



Current medical treatment of pulmonary arterial hypertension
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Current medical treatment of pulmonary arterial hypertension
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018